Today, we are going to evaluate Vertex Pharmaceuticals Incorporated (VRTX) so as to get clarity on this organization and its current standing from a fundamental perspective. In that process, we hope to give some insight into what this stock may offer as an investment opportunity for prospective investors. To accomplish that, we will be moving from top to bottom in our evaluation. As such, our first point of focus will be a look at the company from a revenue perspective.
Over the course of the prior fiscal quarter, the company saw sales of 651.63M[3. Sales mrq]. That number needs context […]
Full Post at www.argusjournal.com